𝐑𝐞𝐭𝐚𝐭𝐫𝐮𝐭𝐢𝐝𝐞 𝟏𝟎 𝐦𝐠

Retatrutide — Triple-Agonist Analytical Reagent

Product Description: Retatrutide is a synthetic peptide and a first-of-its-kind triple agonist, targeting three distinct biochemical pathways: the Glucagon-like peptide-1 (GLP-1) receptor, the Glucose-dependent insulinotropic polypeptide (GIP) receptor, and the Glucagon (GCG) receptor. In laboratory research, this compound is utilized to study the synergistic effects of multi-receptor activation on metabolic signaling and cellular energy expenditure.

Analytical Specifications & Laboratory Safety:

• Verification: Every batch of Retatrutide undergoes rigorous HPLC (High-Performance Liquid Chromatography) and Mass Spectrometry (MS) analysis to ensure structural identity.

• Purity Standards: We guarantee a purity threshold of 99 percent or higher, verified to be free from TFA (Trifluoroacetic acid) and heavy metal contaminants to ensure experimental reproducibility.

• Documentation: Batch-specific Certificates of Analysis (COAs) are provided for every lot to authenticate the chemical profile for research documentation.

Primary Areas of In-Vitro Investigation:

• GLP-1 Receptor Signaling: Studied for its role in modulating cellular signaling pathways and gastric-related enzyme secretion in model systems.

• GIP Pathway Interaction: Investigated for its influence on insulin signaling and lipid handling within specialized cell cultures.

• Glucagon Receptor Activation: Research focuses on the compound's ability to modulate thermogenic pathways and resting energy expenditure in metabolic research models.

Strictly for Research Use Only: This product is a synthetic peptide intended for in vitro laboratory experimentation. It is not for human consumption. While extensively documented for its high safety profile in clinical literature, it remains in the "research only" category for legal compliance.